Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Yisu Gu, a researcher in Professor Fiona Powrie’s group, has been awarded a highly competitive Wellcome Trust Clinical Fellowship to support her research into control of the immune response in chronic inflammatory disease.

As a clinician specialising in haematology, Yisu joined Professor Powrie’s group to learn basic immunology research as well as techniques that can be used to analyse specific types of immune cells.  The funding from the Wellcome Trust will extend Yisu’s initial nine-month placement by another three years, and will support Yisu’s training towards a DPhil in Cell and Molecular Medicine.

Speaking of her award, Yisu said “I am very grateful to the Wellcome Trust for this fellowship, which will give me the opportunity to develop a greater understanding of basic immunology to complement my clinical interests of using immunotherapy to treat haematological malignancies”.

During her fellowship, Yisu will apply advanced imaging techniques to study tertiary lymphoid organs – the discrete structures jam packed with immune cells that form during chronic inflammation. Tertiary lymphoid organs are detected in a range of chronic inflammatory conditions, including inflammatory bowel disease, rheumatoid arthritis, and multiple sclerosis. Yisu’s work aims to establish to what extent these structures promote – or possibly contain – the inflammatory response and disease progression.

The Wellcome Trust Clinical Fellowship scheme is designed to provide training and support for the next generation of clinician scientists. Around 60 fellowships will be awarded in 2016 to support both national and international research.

 

 

 

Similar stories

Major ERC funding awarded to Professor Michael Dustin

Funding General

Professor Michael Dustin and an international team of collaborators have been awarded a €10M grant from the European Research Council (ERC) to develop a new biotechnology around supramolecular attack particles (SMAPs) engineered to kill cancer cells.

Professor Michael Dustin elected to the National Academy of Sciences

Awards

Recognised for his outstanding contributions to the field of immunology, Michael becomes the fourth Kennedy professor to be elected to the Academy.

NDORMS researchers awarded for Dupuytren research

Awards

Three NDORMS researchers have received awards from the International Dupuytren Society, a patient organisation that brings together Dupuytren Disease patient societies from across the world.

Versus Arthritis Foundation Fellowship awarded to Dr Kristina Zec

Awards

Dr Kristina Zec has been awarded a Versus Arthritis Foundation Fellowship to investigate the role of products of lipid oxidation produced by synovial macrophages in triggering articular inflammation.

Oxford University awarded £2.4 million to fund DPhil research in inflammation, immunology and musculoskeletal disease

Awards Funding

Oxford University has today been awarded a £2.4 million grant, as part of the Kennedy Trust MB PhD scheme, to fund undergraduate medical students to undertake DPhil research in the areas of inflammation, immunology and musculoskeletal disease.

£3M invested to drive forward early translation through five new Oxford-Bristol Myers Squibb Fellowships

Awards General

Five new Oxford-Bristol Myers Squibb Fellowships representing an investment of £3M have been announced. The fellowships (formerly Oxford-Celgene) will support postdoctoral researchers and clinicians across five departments within the Medical Sciences Division and the Mathematical, Physical and Life Sciences Division, providing an opportunity for them to gain exposure to the field of commercial drug discovery and development.